SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival

Ruoxi Wang(Shanghai Medical College of Fudan University), Sheng Chen(City University of Hong Kong)
Frontiers in Immunology
October 20, 2022
Cited by 3


Related Papers